H.B. Fuller (NYSE:FUL – Get Rating) released its quarterly earnings data on Wednesday. The specialty chemicals company reported $1.11 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.04, Fidelity Earnings reports. H.B. Fuller had a return on equity of 12.40% and a net margin of 5.39%. During the same quarter last year, the firm posted $0.94 earnings per share. H.B. Fuller updated its FY 2022 guidance to $4.10-$4.35 EPS.
Shares of NYSE:FUL opened at $61.44 on Thursday. The company has a current ratio of 1.87, a quick ratio of 1.11 and a debt-to-equity ratio of 1.15. H.B. Fuller has a 1 year low of $59.17 and a 1 year high of $81.73. The business has a fifty day simple moving average of $67.77 and a 200 day simple moving average of $70.52. The firm has a market cap of $3.26 billion, a price-to-earnings ratio of 18.34 and a beta of 1.60.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 5th. Investors of record on Thursday, April 21st were issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 1.24%. This is a positive change from H.B. Fuller’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend was Wednesday, April 20th. H.B. Fuller’s dividend payout ratio (DPR) is currently 22.69%.
In related news, VP Timothy J. Keenan sold 1,433 shares of the stock in a transaction on Friday, April 8th. The stock was sold at an average price of $68.25, for a total transaction of $97,802.25. Following the completion of the sale, the vice president now directly owns 22,871 shares in the company, valued at $1,560,945.75. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 4.69% of the stock is currently owned by company insiders.
An institutional investor recently raised its position in H.B. Fuller stock. MetLife Investment Management LLC raised its stake in shares of H.B. Fuller (NYSE:FUL – Get Rating) by 55.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,833 shares of the specialty chemicals company’s stock after buying an additional 9,960 shares during the period. MetLife Investment Management LLC owned 0.05% of H.B. Fuller worth $1,839,000 at the end of the most recent quarter. 96.93% of the stock is owned by institutional investors.
H.B. Fuller Company Profile (Get Rating)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
- Get a free copy of the StockNews.com research report on H.B. Fuller (FUL)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.